Next Article in Journal
PARP Inhibitors in Ovarian Cancer: Resistance Mechanisms, Clinical Evidence, and Evolving Strategies
Next Article in Special Issue
Safety and Efficacy of Regorafenib and 5-Fluorouracil Combination Therapy in Refractory Metastatic Colorectal Cancer After Third-Line Treatment: An Institutional Experience
Previous Article in Journal
Impact of Tumor Size on Prolactinoma Characteristics and Treatment Outcomes: A Study of a Tunisian Cohort
Previous Article in Special Issue
The IL-6/JAK/STAT3 Axis in Cholangiocarcinoma and Primary Sclerosing Cholangitis: Unlocking Therapeutic Strategies Through Patient-Derived Organoids
 
 
Article

Article Versions Notes

Biomedicines 2025, 13(5), 1124; https://doi.org/10.3390/biomedicines13051124
Action Date Notes Link
article html file updated 6 May 2025 12:29 CEST Original file https://www.mdpi.com/2227-9059/13/5/1124/html
article xml file uploaded 6 May 2025 12:30 CEST Original file -
article xml uploaded. 6 May 2025 12:30 CEST Update https://www.mdpi.com/2227-9059/13/5/1124/xml
article pdf uploaded. 6 May 2025 12:30 CEST Version of Record https://www.mdpi.com/2227-9059/13/5/1124/pdf
Back to TopTop